Company
Kromatid
The Characterization Company for Cell & Gene Therapy
Also known as KROMATID, Inc
- Status
- Operatingas of 2026-09-19
- Business model
- B2B
- Founded
- 2016
- Customers
- cell and gene therapy researchers, biotech and pharma companies, and regulatory professionals
- Legal name
- KROMATID, Inc
Claim, correct or request removal
Record updated 29 September 2026
About
KromaTiD is a next generation single-cell innovative solutions company for the discovery, detection, and quantification of genomic structural variations for gene and cell therapy researchers.
Funding snapshot
- Total raised
- $16.1MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Round, $3.6M2025-07-01
Funding rounds
- Round, 2025
- $3.6M2025-07-01, SEC form D sold, 57 investors
- Round, 2024
- $2.1M2024-01-17, SEC form D sold, 63 investors
- Round, 2021
- $7.9M2021-09-30, SEC form D sold, 61 investors
- Round, 2019
- $1.9M2019-02-15, SEC form D sold, 4 investors
- Round, 2016
- $623K2016-12-12, SEC form D sold, 16 investors
- Round, 2013
- $50K2013-08-14, SEC form D sold, 1 investor
Products
- Other
- KROMASURE Platform
Loading relationship preview